AI in Biopharma Communications Survey
T2B’s inaugural AI in Biopharma Communications Survey captures how experienced communicators across life sciences, agencies, consulting, and independent roles are using AI in their work today. This benchmark shows a profession moving quickly, while many organizations are still catching up on the tools, training, governance, measurement, and expectations needed to make that use confident, responsible, and strategically valuable.
What we set out to learn
We launched this survey to better understand how AI is showing up in the day-to-day work of biopharma communications: where it is adding value, where communicators feel under-supported, and what the next phase of AI fluency may require for our profession.
The survey captured responses from 117 biopharma communications practitioners across in-house, agency, consulting, and independent roles. Respondents skew senior, reflecting the makeup of the T2B community: 95% are mid-level or above, 40% are advanced senior or executive level, and 44% manage direct reports.
What we found
Biopharma communicators are moving quickly on AI, but support systems are lagging
The clearest signal from the survey is that AI is already changing how experienced communicators work, while organizational systems around access, training, governance, measurement, and expectations are still uneven.
A few findings that stood out
Expectations are shifting faster than they are being defined
Tool access does not always match how communicators actually work
ChatGPT is the most-used tool among respondents, while Copilot is the tool respondents are most likely to say their employer provides or approves. Fifty-eight percent are using tools beyond those supplied by their organization.
Guidance exists, but confidence is still fragile
Most company-employed respondents say their organization has at least some AI guidance, but only 32% say formal policy is actively communicated and enforced. Fewer than half trust their organization or clients to use AI responsibly.
Download the full executive summary
Available to all T2B community members; log into your T2B account to download. If you’re not a member, see if you’re eligible and request to join.
How T2B is supporting the next phase
The survey reinforced what we have been hearing across the T2B community: communicators want more practical, profession-specific support. They are experimenting, comparing notes, and learning by doing, but many still need more time, training, confidence in outputs, and clearer examples of how AI can support higher-value communications work.
That is where T2B will continue to focus: practical programming, peer exchange, and resources that help biopharma communicators use AI with more clarity and confidence.
Our next AI Roundtable event on July 28th will directly address one of the clearest needs identified in the survey: how to think about agentic AI and the shift from prompting to responsible delegation in strategic communications work.
